Oseltamivir analogs with potent anti-influenza virus activity-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Oseltamivir analogs with potent anti-influenza virus activity

Published:2020-08 Issue:8 Volume:25 Page:1389-1402
ISSN:1359-6446
Container-title:Drug Discovery Today
language:en
Short-container-title:Drug Discovery Today

Author:

Kumar Sumit^ORCID,Goicoechea Steven,Kumar Sonu,Pearce Catherine M.,Durvasula Ravi,Kempaiah Prakasha^ORCID,Rathi Brijesh^ORCID,Poonam ^ORCID

Funder

Defence Research & Development Organization (DRDO), Ministry of Defence, Government of India

Department of Science and Technology, Government of India

CSIR, New Delhi

Publisher

Elsevier BV

Subject

Drug Discovery,Pharmacology

Reference81 articles.

1. Synthetic approaches to the neuraminidase inhibitors zanamivir (Relenza) and oseltamivir phosphate (Tamiflu) for the treatment of influenza;Magano;Chem. Rev.,2009

2. Discovery of novel ‘Dual-site’ binding oseltamivir derivatives as potent influenza virus neuraminidase inhibitors;Ai;Eur. J. Med. Chem.,2020

3. Human influenza virus infections;Peteranderl;Semin. Respir. Crit. Care Med.,2016

4. Advances in the development of influenza virus vaccines;Krammer;Nat. Rev. Drug Discov.,2015

5. Pandemic paradox: early life H2N2 pandemic influenza infection enhanced susceptibility to death during the 2009 H1N1 pandemic;Gagnon;mBio,2018

Cited by 20 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Repurposing existing drugs for the treatment ofCOVID-19/SARS-CoV-2: A review of pharmacological effects and mechanism of action;Heliyon;2024-08

2. A Novel Prodrug Strategy Based on Reversibly Degradable Guanidine Imides for High Oral Bioavailability and Prolonged Pharmacokinetics of Broad-Spectrum Anti-influenza Agents;ACS Central Science;2024-07-04

3. Treating influenza with neuraminidase inhibitors: an update of the literature;Expert Opinion on Pharmacotherapy;2024-06-12

4. Analysis of the epidemiological situation of influenza in Guangzhou under the prevention and control of COVID‐19 in June 2022;The Clinical Respiratory Journal;2024-05

5. The Identification Distinct Antiviral Factors Regulated Influenza Pandemic H1N1 Infection;International Journal of Microbiology;2024-01-09

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3